Yangjun Zhang Selected Research

alpha-Fetoproteins (alpha-Fetoprotein)

3/2013

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yangjun Zhang Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 04/2009
5	Carcinogenesis 01/2021 - 11/2011
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2019
3	Liver Neoplasms (Liver Cancer) 01/2019 - 06/2010
3	Sudden Infant Death (SID) 07/2014 - 06/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2019
2	Disease Progression 01/2021 - 06/2017
2	Pathologic Processes 09/2013 - 11/2011
2	Hepatocellular Carcinoma (Hepatoma) 03/2013 - 06/2010
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019
1	Leukemia 01/2019
1	Kidney Neoplasms (Kidney Cancer) 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Lower Urinary Tract Symptoms 05/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2018
1	Erectile Dysfunction 05/2018
1	Autolysis 11/2017
1	Neurologic Manifestations (Neurological Manifestations) 11/2017
1	Ischemic Stroke 11/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Fibrosis (Cirrhosis) 03/2013
1	Hepatitis 03/2013
1	Confusion (Bewilderment) 01/2005
1	Virus Diseases (Viral Diseases) 02/2004

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2009
4	Biomarkers (Surrogate Marker)IBA 02/2019 - 06/2010
4	EnzymesIBA 01/2019 - 04/2009
3	Peptides (Polypeptides)IBA 01/2022 - 04/2009
3	MethyltransferasesIBA 01/2019 - 01/2019
3	Histones (Histone)IBA 01/2019 - 01/2019
3	Lysine (L-Lysine)FDA Link 01/2019 - 01/2019
3	IsotopesIBA 07/2014 - 06/2010
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2019
2	Biological ProductsIBA 01/2019 - 09/2013
1	GlycopeptidesIBA 01/2022
1	PhosphopeptidesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	RNA Splicing FactorsIBA 01/2021
1	AndrogensIBA 01/2021
1	gamma Catenin (Plakoglobin)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Histidine (L-Histidine)FDA Link 10/2020
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 06/2020
1	Trans-Activators (Trans-Acting Factor)IBA 10/2019
1	RNA Precursors (Precursor, mRNA)IBA 10/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Histone-Lysine N-MethyltransferaseIBA 01/2019
1	Immobilized AntibodiesIBA 01/2019
1	SolutionsIBA 11/2017
1	Therapeutic UsesIBA 11/2017
1	TabletsIBA 11/2017
1	Apolipoproteins E (ApoE)IBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2013
1	Annexin A2 (Annexin II)IBA 03/2013
1	Complement System Proteins (Complement)IBA 03/2013
1	ImmunosorbentsIBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 11/2011
1	Polysaccharides (Glycans)IBA 11/2011
1	VitronectinIBA 06/2010
1	ClusterinIBA 06/2010
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 04/2009
1	TeaIBA 04/2009
1	Glutathione (Reduced Glutathione)IBA 04/2009
1	Tryptophan (L-Tryptophan)FDA Link 01/2005
1	CaspasesIBA 02/2004

Therapy/Procedure

2	Therapeutics 01/2021 - 05/2018
1	Castration 01/2019